GNE-3511 |
Inhibitor of MAP3K12
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAP3K12 |
|
|
Inhibitor
up to 50 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - JNK1 129 nM, JNK3 364 nM, MLK1 67.8 nM, MLK2 767 nM, MLK3 602 nM, MKK4 > 5,000 nM, MKK7 > 5,000 nM
Potency Assay Off-Target:
GNE-3511 was assessed against 298 kinases at 0.1 uM in addition to IC50s reported above. Notable off ...
Potency Cellular
In Vitro
MAP3K12
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse, Rat, Dog, Cyno
Dose: 0.4-1 mg/kg (IV), 5 mg/Kg (PO)
Route of delivery:
Intravenous, Oral
Plasma half life:
0.6 (M), 1.8 (R), 4 (D), 2.4 (C) h
Systemic clearance:
56 (M), 30 (R) mL/min/kg
Organ of interest (O):
Brain, CSF
Target engagement assay:
Indirect: inhibition of protein substrate phosphorylation in retina and substantia nigra
Reference: --
Chemical Information
| Molecular Formula | C23H26F2N6O |
| SMILEs | N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1 |
| InChI | InChI=1S/C23H26F2N6O/c24-23(25)4-8-31(15-23)22-11-18(17-2-6-30(7-3-17)19-13-32-14-19)10-21(29-22)28-20-9-16(12-26)1-5-27-20/h1,5,9-11,17,19H,2-4,6-8,13-15H2,(H,27,28,29) |
| Molecular weight | 440.21 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 58 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.